We investigate mechanisms of tumor initiation, progression, and metastasis using molecular and biochemical studies and animal models.
cubeRandom
Novel cancer therapeutics
We apply insights from molecular and genetic studies towards the development of new therapies for lung cancer and other tumor types.
cubeRandom
Functional genetic approaches
We perform unbiased genetic screens to uncover new therapeutic targets for cancer.
cubeRandom
Investigating new mechanisms of immune checkpoint regulation
Integrated stress response-dependent translation of PD-L1 in lung cancer, leading to suppression of anti-tumor immunity. Image depicts PD-L1 protein (left) engaging the T-cell PD-1 receptor (right).